Consolidation treatment of Lenalidomide for patients with adult T-cell leukemia/lymphoma ineligible for hematopoietic stem cell transplant.
Not Applicable
Recruiting
- Conditions
- adult T-cell leukemia/lymphoma
- Registration Number
- JPRN-UMIN000030095
- Lead Sponsor
- orth Japan Hematology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1. Positivity for HBs antigen 2. Positivity for HIV antibody 3. Double cancers 4. Administration of lenalidomide so far 5. Using Dialysis 6. Heat failure or ischemic heart disease 7. Acute hepatitis or Liver cirrhosis 8. Active infection 9. Active thrombotic diseases 10. Allergy for thalidomide 11. Pregnant or breast-feeding woman 12. Difficult of adherence for drug administration 13. Severe mental disorder 14.An inappropriate patient judged by the medical attendant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method